ANRO – alto neuroscience, inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ANRO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

6/17

09:00 am

anro

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright.

Medium Report

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright.

Report

5/27

08:00 am

anro

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright.

Low Report

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright.

Report

5/22

08:00 am

anro

Alto Neuroscience (ANRO) is now covered by Wolfe Research. They set an "outperform" rating on the stock.

Medium Report

Alto Neuroscience (ANRO) is now covered by Wolfe Research. They set an "outperform" rating on the stock.

Report

5/22

08:00 am

anro

Alto Neuroscience (ANRO) is now covered by Wolfe Research. They set an "outperform" rating on the stock.

Medium Report

Alto Neuroscience (ANRO) is now covered by Wolfe Research. They set an "outperform" rating on the stock.

Report

5/18

01:02 pm

anro

Rating for ANRO

Low Report

Rating for ANRO

Report

5/18

01:02 pm

anro

Rating for ANRO

Low Report

Rating for ANRO

Report

5/14

09:05 am

anro

Rating for ANRO

Medium Report

Rating for ANRO

Report

5/14

09:05 am

anro

Rating for ANRO

Medium Report

Rating for ANRO

Report

5/14

09:00 am

anro

Alto Neuroscience (ANRO) had its "neutral" rating reaffirmed by Wedbush.

Medium Report

Alto Neuroscience (ANRO) had its "neutral" rating reaffirmed by Wedbush.

Report

5/14

09:00 am

anro

Alto Neuroscience (ANRO) had its "neutral" rating reaffirmed by Wedbush.

Medium Report

Alto Neuroscience (ANRO) had its "neutral" rating reaffirmed by Wedbush.

Report

5/11

01:51 pm

anro

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.

Medium Report

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.

Report

4/22

04:06 pm

anro

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $30.00 price target on the stock.

Medium Report

Alto Neuroscience (ANRO) had its "buy" rating reaffirmed by Chardan Capital. They now have a $30.00 price target on the stock.

Report

4/22

04:01 pm

anro

Rating for ANRO

Medium Report

Rating for ANRO

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.